
1. malar j. 2016 apr 12;15:202. doi: 10.1186/s12936-016-1263-0.

global genetic diversity plasmodium vivax transmission-blocking vaccine
candidate pvs48/45.

vallejo af(1), martinez nl(1), tobon a(1), alger j(2), lacerda mv(3), kajava
av(4)(5), arévalo-herrera m(6)(7), herrera s(8).

author information: 
(1)malaria vaccine drug development center, cali, colombia.
(2)facultad de ciencias médicas, hospital escuela universitario, universidad
nacional autónoma de honduras, tegucigalpa, honduras.
(3)fundação de medicina tropical dr. heitor vieira dourado, manaus, brazil.
(4)centre de recherches biochimie macromoléculaire (crbm), institut de biologie
computationnelle (ibc), cnrs, university montpellier, montpellier, france.
(5)institute bioengineering, university itmo, saint petersburg, russia.
(6)caucaseco scientific research center, cali, colombia.
(7)school health, universidad del valle, cali, colombia.
(8)caucaseco scientific research center, cali, colombia. sherrera@inmuno.org.

background: plasmodium vivax 48/45 protein expressed surface of
gametocytes/gametes plays key role gamete fusion fertilization.
this protein recently expressed escherichia coli host recombinant
product highly immunogenic mice monkeys induced antibodies
with high transmission-blocking activity, suggesting potential p. vivax 
transmission-blocking vaccine candidate. determine sequence polymorphism of
natural parasite isolates potential influence protein structure,
all pvs48/45 sequences reported databases around world well as
those low-transmission settings latin america compared.
methods: plasmodium vivax parasite isolates malaria-endemic regions of
colombia, brazil honduras (n = 60) used sequence pvs48/45 gene,
and compared previously reported genbank plasmodb (n = 222).
pvs48/45 gene haplotypes analysed determine functional significance
of genetic variation protein structure vaccine potential.
results: nine non-synonymous substitutions (e35k, y196h, h211n, k250n, d335y,
e353q, a376t, k390t, k418r) three synonymous substitutions (i73, t149, c156) 
that define seven different haplotypes found among 282 isolates from
nine countries compared sal reference sequence. nucleotide
diversity (π) 0.00173 worldwide samples (range 0.00033-0.00216),
resulting relatively high diversity myanmar colombia, low diversity
in mexico, peru south korea. two frequent substitutions (e353q:
41.9 %, k250n: 39.5 %) predicted located antigenic regions without 
affecting putative b cell epitopes tertiary protein structure.
conclusions: limited sequence polymorphism pvs48/45 noted
geographical clustering among asian american isolates. low genetic
diversity protein influence predicted antigenicity protein
structure and, therefore, supports development as
transmission-blocking vaccine candidate.

doi: 10.1186/s12936-016-1263-0 
pmcid: pmc4828788
pmid: 27067024  [indexed medline]

